Treatment with anti-PD-1 or PD-L1 antibodies restores neutrophil, monocyte, NK cell, and T-cell function, emphasizing the role of the PD-1/PD-L1 axis in sepsis-induced immunosuppression and the ability of a single immunomodulator to treat infectious diseases [98]. The gene discussed is PDCD1; the disease is infectious disease.